Umbrella Study for Single Patient Treatments in Oncology
Advanced Cancer | Rare DiseasesThe purpose of this study is to collect data on how advanced and rare cancers respond to biomarker-based treatments.
null
Participation Requirements
-
Sex:
ALL -
Eligible Ages:
18 and up
Participation Criteria
Inclusion Criteria \& Exclusion Criteria:
Patient's existing genomic information from tumor molecular profiling will be discussed in the hospital expert molecular tumor board rounds consisting of representatives from specialist genomic profiling and medical oncology departments to decide N of 1 treatment for the patient. The discussion will surround the best next therapeutic option in the patient's cancer subtype with or without clear standard of care guidelines. Therefore, specific eligibility criteria aside from individual patient's medical history is not applicable.
Study Location
University Health Network, Princess Margaret Cancer Centre
University Health Network, Princess Margaret Cancer CentreToronto, Ontario
Canada
Contact Study Team
- Study Sponsored By
- University Health Network, Toronto
- Participants Required
- More Information
- Study ID:
NCT06285500